JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
85 Sun, 8/9/2015, 4:00 PM - 5:50 PM CC-611
Biomarkers and Endpoint Validation 1 — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Samir Lababidi,
4:05 PM Sequential Monitoring of Clinical Trials with a Stepped Wedge Design — Siobhan Brown, University of Washington ; Abigail Shoben, The Ohio State University
4:20 PM Statistics to Aid Decision Making for Early-Phase Cancer Trials with Time-to-Event Endpoints — Shaoyi Li, Celgene
4:35 PM Sequential Basket Design with Subgroups Defined by Predictive Biomarker and Cancer — Shuai Yuan, Merck
4:50 PM Using Correlation Patterns of Study Findings to Assess Data Quality in Clinical Trials — Richard Zink, SAS Institute
5:05 PM MOST: Multi-Stage Optimal Sequential Trial Design for Phase II Clinical Trials with Biomarker Subgroups — Yong Zang, Florida Atlantic University
5:20 PM Model-Based Meta-Analysis of Clinical Dose Response for Biological Products — Joseph Wu, Pfizer Inc. ; Anindita Banerjee, Pfizer Inc. ; Bo Jin, Pfizer Inc. ; Sandeep Menon, Pfizer Inc. ; Steven Martin, Pfizer Inc.
5:35 PM Floor Discussion




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home